|
Paxillin
|
D051419 |
[Paxillin is a signal transducing adaptor protein that localizes to FOCAL ADHESIONS via its four LIM domains. It undergoes PHOSPHORYLATION in response to integrin-mediated CELL ADHESION, and interacts with a variety of proteins including VINCULIN; FOCAL ADHESION KINASE; PROTO-ONCOGENE PROTEIN PP60(C-SRC); and PROTO-ONCOGENE PROTEIN C-CRK.
] |
|
Apolipoprotein A-II
|
D10.532.091.200.150 |
|
|
Hepatitis Antibodies
|
D12.776.124.790.651.114.254.450 |
|
|
Netherton Syndrome
|
C17.800.428.333.250.705 |
|
|
alpha-Crystallin B Chain
|
D12.776.580.157.300 |
|
|
alpha-Crystallins
|
D12.776.580.157 |
|
|
Nucleoproteins
|
D12.776.664 |
|
|
Trichlormethiazide
|
D03.633.100.174.261.476.716 |
|
|
Hydrochlorothiazide
|
D03.633.100.174.261.476 |
|
|
Hospitalists
|
N02.360.630.490.400 |
|
|
Medical Staff, Hospital
|
N02.360.630.490 |
|
|
Carcinoma, Ehrlich Tumor
|
C04.619.169 |
|
|
Neoplasms, Experimental
|
C04.619 |
|
|
Solifenacin Succinate
|
D03.633.100.531.820.594 |
|
|
Health Maintenance Organizations
|
N04.590.374.410.400 |
|
|
Afibrinogenemia
|
C15.378.463.067 |
|
|
Panniculitis, Lupus Erythematosus
|
C17.800.480.479.400 |
|
|
Lupus Erythematosus, Discoid
|
C17.800.480.479 |
|
|
Neurocutaneous Syndromes
|
C17.800.804.350.712 |
|
|
Apolipoprotein E3
|
D12.776.070.400.500.500 |
|
